Cell Reports (Nov 2017)

Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer’s Disease-like Pathology

  • Jeffrey N. Savas,
  • Yi-Zhi Wang,
  • Laura A. DeNardo,
  • Salvador Martinez-Bartolome,
  • Daniel B. McClatchy,
  • Timothy J. Hark,
  • Natalie F. Shanks,
  • Kira A. Cozzolino,
  • Mathieu Lavallée-Adam,
  • Samuel N. Smukowski,
  • Sung Kyu Park,
  • Jeffery W. Kelly,
  • Edward H. Koo,
  • Terunaga Nakagawa,
  • Eliezer Masliah,
  • Anirvan Ghosh,
  • John R. Yates, III

DOI
https://doi.org/10.1016/j.celrep.2017.11.009
Journal volume & issue
Vol. 21, no. 9
pp. 2614 – 2627

Abstract

Read online

Amyloid beta (Aβ) peptides impair multiple cellular pathways and play a causative role in Alzheimer’s disease (AD) pathology, but how the brain proteome is remodeled by this process is unknown. To identify protein networks associated with AD-like pathology, we performed global quantitative proteomic analysis in three mouse models at young and old ages. Our analysis revealed a robust increase in Apolipoprotein E (ApoE) levels in nearly all brain regions with increased Aβ levels. Taken together with prior findings on ApoE driving Aβ accumulation, this analysis points to a pathological dysregulation of the ApoE-Aβ axis. We also found dysregulation of protein networks involved in excitatory synaptic transmission. Analysis of the AMPA receptor (AMPAR) complex revealed specific loss of TARPγ-2, a key AMPAR-trafficking protein. Expression of TARPγ-2 in hAPP transgenic mice restored AMPA currents. This proteomic database represents a resource for the identification of protein alterations responsible for AD.

Keywords